Cellular DNA content--a stable feature in epithelial ovarian cancer. by Friedlander, M. L. et al.
Br. J. Cancer (1984), 49, 173-179
Cellular DNA content a stable feature in epithelial ovarian
cancer
M.L. Friedlander', I.W. Taylor', P. Russell2 and M.H.N. Tattersall'
'Ludwig Institutefor Cancer Research (Sydney Branch), Blackburn Building, University ofSydney, Sydney,
N.S. W. 2006 and 2Department ofAnatomical Pathology, King George V Memorial Hospital, Camperdown,
N.S.W. 2050, Australia.
Detailed flow cytometric analysis of cellular DNA content was performed on neoplastic tissue from 33
patients with malignant common epithelial ovarian tumours in order to investigate the intratumoral stability
of ploidy and proliferative fraction. There was a remarkable stability, both spatial and temporal, in the DNA
pattern for any particular tumour. Of 24 tumours that were analysed in multiple areas tumour ploidy was
found to be a stable marker in all but 3 cases where regional variations were evident. In 9 patients serial
analyses were performed on tumour obtained either at initial diagnosis (6 patients) or second look
laparotomy (3 patients) and then some time later (7-17 months) at relapse or death and in all cases the
tumour ploidy remained unchanged. In addition, 10 ovarian carcinomas established in nude mice have
maintained a DNA content during serial passage similar to that of the original implanted tumour. In contrast
in 50% of tumours that were evaluable for S-phase analysis we demonstrated a considerable intratumoral
variability in the S-phase fraction.
We conclude that cellular DNA content is a stable feature of ovarian carcinoma while S-phase fraction is
commonly subject to intratumoral variation.
The flow cytometric determination of cellular DNA
content has been shown to be of prognostic value
in a number of tumour types (Bunn et al., 1982;
Wolley et al., 1982) and we have recently reported
that tumour ploidy was an independent prognostic
variable and the major determinant of survival in
patients with advanced ovarian cancer (Friedlander
et al., 1983a). The value of a single estimation of
tumour ploidy would be clearly limited however if
tumours commonly exhibited a variation in ploidy
within different regions of the primary tumour or
its metastases. Such variability has been reported in
colonic cancer (Petersen et al., 1981) and small cell
lung cancer (Vindelov et al., 1980) but there are no
studies that have addressed the stability of cellular
DNA content as determined with flow cytometry in
ovarian tumours. We report the results of a study
investigating the frequency of intratumoral
heterogeneity of cellular DNA content and
proliferative fraction (S-phase) in ovarian
carcinomas.
Materials and methods
Tumour specimens for flow cytometric analysis and
histological examination were obtained from 33
patients with ovarian carcinoma and multiple areas
(mean 4, range 2-12) were biopsied from either the
primary tumour alone (8 FIGO I and II tumours)
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or from the metastatic sites as well when the patient
had advanced stage disease (16 patients). Particular
attention was paid to include biopsies from the
peripheral and central regions of a tumour mass
when possible. In an additional 9 patients it was
possible to analyse tumour ploidy sequentially on
specimens obtained at either initial diagnosis (6
cases) or from residual tumour found at second
look laparotomy (3 cases) and then at subsequent
relapse. Operative specimens were received fresh
from the operating theatres and tumour tissue was
subdivided in the pathology department for flow
cytometry and histological examination. DNA flow
cytometry was usually performed within 2h of
operative removal of tumour from the patient but if
not, samples were stored at -70°C prior to
analysis. Ascitic or pleural fluid specimens were
examined cytologically and flow cytometrically
immediately following aspiration.
Flow cytometry
DNA content All specimens were analysed on an
ICP 22 flow cytometer (Ortho-Instruments,
Westwood, MA). Specimens were processed and
stained for DNA content with ethidium bromide
and mithramycin in a single step staining technique
that has been fully described elsewhere (Taylor,
1980). Briefly, for solid tumours 250pd of a 1%
Triton-x-100 solution containing 400pgml-1 ethi-
dium bromide and 250y1 of a 1% triton solution
containing 125jigml mithramycin and 75mM
magnesium chloride were added to 2ml of RPMI
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1640 medium containing 10% foetal calf serum. A
2ml aliquot of this staining solution plus 200p1
chicken red blood cells (CRBC; 106ml-1) were
added to a small piece of tumour tissue
(5mm x 5mm) in a petri dish and the tissue was
finely disaggregated with scalpel blades. A further
2ml of staining solution were added, the solution
gently pipetted several times and the preparation
filtered through an 80pm nylon mesh filter. This
preparation results in a suspension of isolated
nuclei from which almost all cytoplasm has been
removed. RNA-ase (ribonuclease Type IA, Sigma
Chemical Company) was added to the suspension
just prior to analysis to give a final concentration
of lmgml-1.
Chicken red blood cells (CRBC) were used as an
internal marker, as the ratio of the G1 DNA
content of human diploid cells to the DNA content
of CRBC is highly reproducible (2.9+0.17) under
the staining conditions used (Taylor & Milthorpe,
1980). Using this standard all the tumour specimens
analysed contained a population of cells with a
diploid DNA content. When this was the only cell
population present the tumour was classified as
diploid, while tumours which had evidence of an
additional G1 peak were classified as aneuploid.
Where in addition to the diploid G1 peak there was
clear evidence of more than one aneuploid G1 peak
the tumour was classified as multiploid. Ploidy was
further quantitated by the DNA Index (DI) which
represents the relative DNA content of the
aneuploid G1 cells in comparison to diploid cells
(Barlogie et al., 1980). Thus, a DI of 1 is
synonymous with a normal diploid DNA content.
The mean coefficient of variation of the diploid or
aneuploid G1 peak was 2.7% in all tumours studied
(range 1.2-5.1).
In order to determine the sensitivity of the
method of detecting an aneuploid tumour
population, normal human lymphocytes (diploid)
were admixed with an aneuploid ovarian cell line
(DI= 1.59). Varying amounts of aneuploid cells
were mixed with human lymphocytes to give a final
cell concentration of 106ml-1 with an aneuploid
cell content ranging from 0.5%-95%. The cells
were stained with ethidium bromide and
mithramycin as described above.
Proliferative fraction The proportion of cells in S-
phase was estimated by computer analysis in 16
tumours using a planimetric method of analysis
(Milthorpe, 1980). Overlapping of subpopulations
was the major reason for omitting tumour samples
from analysis and while all diploid tumours could
be analysed, in only 50% of tumours with
aneuploid cells was S-phase analysis attempted.
Xenografted tumours
Balb/C nu/nu strain female nude mice were
inoculated with fragments of ovarian tumour tissue
as previously described (Van Haaften-Day et al.,
1983). All tumours had DNA analysis and
histological examination performed prior to
implantation and with each serial passage.
Results
Comparison of tumour ploidy within primary tumour
and metastases
Twenty-four patients had tumour ploidy
determined either from different sites within the
primary tumour alone (8 cases) or from the
metastatic sites as well in those patients with
advanced stage disease. Thirty-three percent of the
patients had diploid tumours and 67% had
aneuploid tumours. Figure 1 outlines the
distribution of DNA content and demonstrates a
clustering of tumour cells about a diploid and
triploid-tetraploid mode. The majority of tumours
(87%), exhibited a stable DI in all sites analysed
(Figure 2) and this regional stability of DNA
content was also evident in 2 multiploidal tumours
(Figure 3). The 3 exceptions (all Stage III tumours)
included a tumour which was initially classified as
diploid but had an additional tetraploid G1 peak
demonstrated in one region and two aneuploid
tumours which showed regional variations of
aneuploidy (Figure 4). Only one of these tumours
had concomitant regional histological differences
which correlated with the ploidy variations (a
mixed epithelial carcinoma with adenosquamous
and typical serous carcinoma in different areas).
Although the DI was stable in different areas of
most tumours there were nevertheless often regional
variations (for examples, see Figure 4) in the actual
proportion of aneuploid to diploid cells. We
determined the sensitivity of flow cytometry in
detecting aneuploid populations and under
controlled conditions demonstrated that a 1%
concentration of aneuploid cells admixed with
normal human lymphocytes could be identified
(Figure 5).
Sequential analysis ofDNA content
Nine patients had DNA analysis performed on
sequential tumour specimens. The initial specimen
was obtained either at initial diagnosis or at a
second look laparotomy where residual tumour
remained after chemotherapy. Tumour DNA
analysis was repeated in all patients at a subsequent
relapse or death with a mean interval of timeSTABILITY OF PLOIDY 175
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Figure 1 Frequency histogram showing the distribution of ploidy in tumours from 24 patients with ovarian
cancer. Ploidy is expressed as DNA index (DI) which represents the relative DNA content of tumour GI to
diploid GI cells. All tumours analysed contained a population of cells with a diploid DNA content and when
this was the only cell population present the tumour was classified as diploid (DNA index 1). When there was
an additional G, peak the tumour was classified as aneuploid and in such cases the diploid component was
assumed to be made up of normal cells. Five tumours had 2 aneuploid G, peaks while the rest had a single
tumour G, peak.
between the first and second DNA analysis of 9
months (range, 7-15 months). Two patients initially
had diploid tumours and 7 had aneuploid tumours
and the DI of all tumours remained unchanged at
the time of relapse or death (Table I).
Xenografted ovarian tumours
Ten epithelial ovarian carcinomas were established
directly in nude mice and histological examination
Table I Comparison of DNA index at diagnosis and at
time of relapse or death
Patient Initial DNA index DNA index at relapse
2
3
4
5
6
7
8
9
0.85
0.9
I
1
1.17
1.31
1.73
1.78
1.83
0.83
0.85
1
1
1.15
1.31
1.73
1.77
1.79
and DNA analyses were performed on tumour
tissue just prior to implantation and repeated at
each subsequent passage. The DI (Table II) and
histological features have remained essentially
unchanged during the serial passage of all tumours
to date (median time= 12 months).
Table II Comparison of DNA index of ovarian tumour
xenografts passaged in nude mice with the DNA index of
original tumour
Original DI afier
DI of passage in No. of
Tumour fresh tumour niude nmice passages
1 1.64 1.73 4
2 2.60 2.53 2
3 0.86 0.92 6
4 1.45 1.60 4
5 1.35 1.40 3
6 1.33 1.42 3
7 2 2 5
8 1.47 1.52 6
9 1 1 3
10 1.72 1.9 3
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Figure 2 Histogram to demonstrate the relative
regional stability of tumour ploidy and relative
regional variation of S-phase fraction in 24 ovarian
cancers sampled in different areas of the tumour.
Apart from 1 predominantly diploid tumour which
had evidence of an additional tetraploid component in
one area and 2 aneuploid tumours which exhibited
regional variations of aneuploidy tumour ploidy was a
stable marker. S-phase analysis was possible in all
diploid tumours but only in 50% of aneuploid
tumours as overlapping of cell populations precluded
accurate analysis. A 40% or greater variation of S-
phase was evident within different areas of the same
tumour in half the cases analysed.
Regional S-phase variation
Of the 24 tumours studied for regional variations in
DNA content all 8 diploid tumours were evaluable
for S-phase analysis while overlapping of cell
populations precluded an S-phase estimation in half
the tumours with aneuploid cells. Diploid tumours
had a mean S-phase of 6.6% (range, 3.4-16.2%)
and aneuploid tumour cells a mean S-phase of
17.3% (range, 3.7-33.6%). In 8 of the tumours
(50%) there was a 40% or greater variation of S-
phase (Figure 2) in different sites.
Discussion
Flow cytometric analysis allows tumour DNA
content and proliferative activity to be determined
rapidly and precisely and their value as possible
objective parameters reflecting tumour biology is of
intense interest. We have shown that cellular DNA
content is an independent prognostic variable and a
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Figure 3 Demonstration of stability of DNA content
in a multiploid tumour. There is evidence of 2
aneuploid clones in both the primary tumour and
omental metastases. Note the resolving power of the
instrument in discriminating the 2 diploid peaks.
Channel no., relative fluorescence intensity (DNA
content). Ordinate, number of cells.
major determinant of survival in advanced ovarian
cancer (Friedlander et al., 1983a) and similar
findings have been reported in other malignancies
(Bunn et al., 1982; Wolley et al., 1982). There is
however, some evidence that regional variations in
tumour ploidy are common in colonic carcinomas
(Petersen et al., 1981) and small cell lung cancer
(Vindelov et al., 1980) and the heterogeneity of
such tumours casts doubts on the value of a single
estimation of ploidy as a prognostic index for all
tumour types. We have therefore studied the
stability of cellular DNA content in common
epithelial ovarian cancer.
While ovarian tumours as a group are widely
heterogeneous with respect to DNA content (Atkin,
1970; Friedlander et al., 1983b) with early stage
ovarian cancers being commonly diploid and
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Figure 4 DNA histograms of a tumour that exhibited
a regional variation in aneuploidy. Channel number
represents fluorescence intensity which is directly
proportional to DNA content. The numbet of cells
counted are shown on the ordinate. The first peak
corresponds to chicken red blood cells (CRBC) which
acts as an internal biological standard and is set in
channel 10. The next major peak represents the diploid
G1 peak. Note that in subset c only one aneuploid
population is evident while in subsets a and b two
aneuploid populations are present but the relative
proportions vary.
advanced stage carcinomas commonly aneuploid,
we demonstrate in this study that within an
individual tumour intratumoral variations of ploidy
are uncommon, occurring in only 13% of cases.
These findings support those of an earlier study
where, using Feulgen microspectrophotometry,
ovarian cancers were shown to have a stable DNA
content within different sites (Atkin, 1970). Further
evidence of the stability of cellular DNA content in
epithelial ovarian cancer is provided by finding that
in ovarian tumours established in nude mice the DI
remains unchanged during serial passage. The mean
variation of the DI before and after passage in
nude mice was 4.5% (range, 0-10%). This is in
keeping with the variation that can be expected by
possible staining and instrumental variation (Taylor
& Milthorpe, 1980).
It was possible to determine the stability of
cellular DNA content during tumour progression in
9 patients by analysing tumour specimens obtained
at initial diagnosis or at a second look laparotomy
and then again 7-17 months later at the time of
relapse or death and in all cases the DI remained
unchanged. All these patients had initially
responded to chemotherapy with cis-platinum
and/or chlorambucil and had later relapsed. It is
interesting that there was a reappearance of clones
with the same DNA content as that found prior to
treatment, which suggests some stability of the
genome. There could however be chromosomal
variability associated with disease progression but
masked either by minor changes undetectable with
flow cytometry (Barlogie et al., 1977) or because
chromosomal number variability may be due to a
DNA packaging defect which would not be
reflected by a change in the DNA content
(Kraemer et al., 1971). Only a small number of
cases have been reported where serial karyotyping
and banding studies have been performed following
the progression of ovarian tumours and such
studies show that the karyotype remains basically
unchanged during tumour progression with
changes, when present, representing a variation in
the theme already observed in the original tumours
(Atkin, 1970; MacKillop et al., 1983; Sandberg,
1982).
While the DI remains constant within a primary
tumour and its metastases the proportion of
aneuploid cells often varies from one region to
another. This feature has been interpreted by some
(Nervi et al., 1982) as evidence of intratumoral
heterogeneity but it is likely that these variations
reflect different degrees of admixing of normal
diploid cells with aneuploid tumour cells rather
than changes of biological significance. We cannot
rule out entirely the possibility that cells with a
diploid DNA content in tumours with bimodal
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Figure 5 Determination of the sensitivity of flow cytometry in detecting an aneuploid cell population.
Vaiying concentrations of aneuploid cells were admixed with human lymphocytes (diploid) to determine the
sensitivity of detection of aneuploidy. A 1% or greater content of aneuploid cells could be detected
particularly by collecting up large numbers of cells and amplifying the vertical scale. The broken line
represents a 100 xmagnification of an aneuploid population. Channel number, relative fluorescence intensity
(DNA content). Ordinate, number ofcells. The major G1 peak represents diploid lymphocytes and the smaller
peak at channel number 70 the aneuploid population.
DNA distributions could represent an additional
tumour clone but a number of studies have shown
that in these circumstances the diploid cells usually
represent normal cells (Barlogie et al., 1978; Perez
et al., 1981).
We determined the sensitivity of flow cytometry
to detect aneuploid tumour cells admixed with
normal cells under controlled conditions and
showed that as low as a 1% content of tumour cells
could be detected. However, for practical purposes,
we suggest the limit of detection of an aneuploid
cell population is between 5% and 10% of the cells
analysed due to the presence of background debris
and the possible masking effect of the S-phase and
G2+M components of diploid cells. Histological
examination of all specimens analysed is therefore
necessary to ensure that they contain adequate and
representative portions of tumour tissue. This
assumes particular importance in diploid tumours
where the finding may have important prognostic
implications, as these tumours have a more
favourable natural history than aneuploid tumours
(Atkin, 1970; Bunn et al., 1982, Friedlander et al.,
1983b; Wolley et al., 1982). The actual degree of
aneuploidy (i.e. DI of tumour) or the presence of
multiploidy has not been demonstrated to date to
be of significance and although it has been
suggested by some that multiploid tumours may
have a more aggressive natural history (Taylor et
al., 1983; Vindelov et al., 1980), we could not
confirm this in patients with advanced ovarian
cancer. All 3 patients who had regional variations
in ploidy in this study relapsed within 6 months of
diagnosis and it is possible that an unstable DNA
content identifies high risk patients.
The S-phase as determined flow cytometrically
has been reported to be a reflection of the
aggressiveness of tumour behaviour and to be of
prognostic significance (Costa et al., 1981). The S-
phase can be determined in all diploid tumours but
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only in - 50% of aneuploid tumours because of
overlapping of tumour populations. While we and
others have demonstrated that diploid tumours
have a lower S-phase than aneuploid tumours, it is
possible that the values for S-phase in diploid cells
have been artificially lowered by the presence of
normal non-cycling diploid cells e.g. lymphocytes
(Dosik et al., 1980), while aneuploid tumours could
have a higher S-phase because of the presence of
diploid doublets and tetraploid normal cells. In this
study we found that up to 50% of tumours showed
a significant regional variation in the S-phase
fraction (>40% variation in different areas). The
reasons for this variability are not known but could
relate either to different proliferative states among
tumour cells in different nutritional environments,
or to variable contamination of tumour cells by
normal non-cycling cell populations. The value of a
single S-phase estimation is therefore clearly limited
in the light of these findings, as are data relating to
the prognostic value of S-phase in ovarian cancer.
We conclude that DNA content is a stable
feature in most cases of epithelial ovarian cancer
exhibiting constancy within the primary tumour, its
metastases and during subsequent tumour
progression. On the other hand, the S-phase
fraction is often subject to considerable
intratumoral variation. These results cannot
necessarily be extrapolated to other tumour types
where similar studies are required to establish the
representative value of a single estimation of
tumour DNA content or proliferative fraction.
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